The Executive Committee on Personalized Health and Related Technologies (PHRT) has supported the PROGNOSTIC translational Project with a Grant of CHF 2 million

Group Prognostik

About PROGNOSTICS: “PROGNOSTICS: PeRsOnalized theraGNOstics of metaStaTIC proState cancer” 

The consortium will test an innovative drug that precisely targets the tumor and emits radiation in its vicinity. The safety of the drug and the first signs of response to the drug are being evaluated as part of these studies.